Because T cells can eliminate cancer cells (141), directly targeting the epigenome in tumor-infiltrating CD8+ T cells to preserve their effector functions is another strategy being explored in combination with ICIs (Table 1) (81, 142–144). The gene discussed is CD8A; the disease is neoplasm.